Alerian MLP ETF

54.86

+0.11000.20%

Volume:478.31K

Turnover:26.18M

Market Cap:13.27B

PE:5.33

High:54.97

Open:54.67

Low:54.52

Close:54.75

52wk High:55.66

52wk Low:44.64

Shares:241.93M

Float Shares:241.93M

Volume Ratio:0.44

T/O Rate:0.20%

Dividend:4.07

Dividend Rate:7.42%

EPS(TTM):10.30

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Dow Jones

·

Aug 11

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AMLP/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AMLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLP\",,,,,undefined,":{"symbol":"AMLP","market":"US","secType":"STK","nameCN":"Alerian MLP ETF","latestPrice":54.86,"timestamp":1787595358440,"preClose":54.75,"halted":0,"volume":478305,"delay":0,"changeRate":0.002009132420091314,"floatShares":241932420,"shares":241932420,"eps":10.3,"marketStatus":"Trading","change":0.11,"latestTime":"08-24 14:16:00 EDT","open":54.67,"high":54.97,"low":54.515,"amount":26184381.533549998,"amplitude":0.008311,"askPrice":54.88,"askSize":339,"bidPrice":54.86,"bidSize":168,"shortable":3,"etf":1,"ttmEps":10.3,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":54.75,"sharesOutstanding":227632420,"nav":54.8,"aum":13267403654.61,"dividendRate":0.074154,"bidAskSpread":0.000236,"preHourTrading":{"tag":"盘前","latestPrice":54.62,"preClose":54.75,"latestTime":"09:25 EDT","volume":544,"amount":29808.13184,"timestamp":1787577936323,"change":-0.13,"changeRate":-0.002374,"amplitude":0.013699},"postHourTrading":{"tag":"盘后","latestPrice":54.9,"preClose":54.75,"latestTime":"19:45 EDT","volume":404,"amount":22165.22,"timestamp":1787355909992,"change":0.15,"changeRate":0.00274,"amplitude":0.00274},"volumeRatio":0.438371,"impliedVol":0.1388,"impliedVolPercentile":0.3944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLP\",,,,,undefined,":{"symbol":"AMLP","floatShares":241932420,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.438371,"shares":241932420,"dividePrice":4.0681,"high":54.97,"amplitude":0.008311,"preClose":54.75,"low":54.515,"week52Low":44.64,"pbRate":"--","week52High":55.66,"institutionHeld":0,"latestPrice":54.86,"committee":-0.337278,"eps":10.3,"divideRate":0.074154,"volume":478305,"delay":0,"ttmEps":10.3,"open":54.67,"prevYearClose":47.02,"prevWeekClose":54.75,"prevMonthClose":55.32,"prevQuarterClose":51.85,"fiveDayClose":54.69,"twentyDayClose":54.23,"sixtyDayClose":52.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMLP\",params:#limit:5,,,undefined,":[{"date":"2026-08-12","symbol":"AMLP","amount":1.03,"announcedDate":"2026-08-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-12","defaultRemindTime":1786541400000,"name":"Alerian MLP ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-17","payableDate":"2026-08-12","currency":"USD","dateTimestamp":1786507200000,"payDate":"2026-08-17"},{"date":"2026-05-13","symbol":"AMLP","amount":1.03,"announcedDate":"2026-05-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-13","defaultRemindTime":1778679000000,"name":"Alerian MLP ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-18","payableDate":"2026-05-13","currency":"USD","dateTimestamp":1778644800000,"payDate":"2026-05-18"},{"date":"2026-02-11","symbol":"AMLP","amount":1.01,"announcedDate":"2026-02-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-11","defaultRemindTime":1770820200000,"name":"Alerian MLP ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-17","payableDate":"2026-02-11","currency":"USD","dateTimestamp":1770786000000,"payDate":"2026-02-17"},{"date":"2025-11-12","symbol":"AMLP","amount":1,"announcedDate":"2025-11-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-12","defaultRemindTime":1762957800000,"name":"Alerian MLP ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-17","payableDate":"2025-11-12","currency":"USD","dateTimestamp":1762923600000,"payDate":"2025-11-17"},{"date":"2025-08-13","symbol":"AMLP","amount":0.98,"announcedDate":"2025-08-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-13","defaultRemindTime":1755091800000,"name":"Alerian MLP ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-18","payableDate":"2025-08-13","currency":"USD","dateTimestamp":1755057600000,"payDate":"2025-08-18"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-09","recordDate":"2016-11-14","paymentDate":"2016-11-17","value":0.24,"currency":"USD"},{"executeDate":"2017-02-08","recordDate":"2017-02-10","paymentDate":"2017-02-15","value":0.225,"currency":"USD"},{"executeDate":"2017-05-10","recordDate":"2017-05-12","paymentDate":"2017-05-17","value":0.215,"currency":"USD"},{"executeDate":"2017-08-09","recordDate":"2017-08-11","paymentDate":"2017-08-16","value":0.215,"currency":"USD"},{"executeDate":"2017-11-09","recordDate":"2017-11-10","paymentDate":"2017-11-15","value":0.2052,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMLP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMLP\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658959553","title":"Press Release: Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959553","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959553?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392360,"startTime":"0","endTime":"0","summary":"tolerability and efficacy of DMR-001 in patients with mutCALR-driven ET. and MF, based on receipt of health authority approval. The Phase 1 dose. escalation portion of the trial is designed to rapidly identify a. recommended dose for expansion cohorts, with a starting dose of 100 mg.  expected to be in the range of anticipated. therapeutic exposure and an adaptive Bayesian design enabling cohort. enrichment. The planned Phase 1b expansion portion of the trial will. further evaluate the safety and efficacy of DMR-001 in additional. populations and settings, including in early-line disease and in. combination with other therapies. Read the press release here.-- Presented DMR-001 preclinical data at the EHA 2026 Congress (Abstract. preclinical studies versus a reference anti-mutCALR antibody, DMR-001. showed up to 30-fold higher binding affinity for mutCALR, 26-fold greater. inhibition of cellular proliferation in Type 2 mutCALR, an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DMRA","XELA","BK4134","ET","USAI","UMI","BK4561","BK4590","BK4539","EIPI","EMLP","AMLP","TPZ","BK4526","BK4563","BK4581","TNGY","EIPX","BK4585","AMZA","MDST","BK4139","BK4144","BK4113","BK4588","ENFR","BK4106","BK4007","BK4226","MLPA","MF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":201,"code":"91000000","status":"200"}]}}